Enrolling now: quizartinib plus standard therapy for newly-diagnosed AML
Phase 3 MIDAS trial assesses MRD-driven approach to consolidation, maintenance therapy in myeloma
NCCN recommends pemivibart for BCL patients at risk of severe COVID-19
Early palliative care integration does not reduce MM patients’ healthcare utilization
Ingredient in popular energy drinks linked to leukemia growth

Join SOHO

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

MDS News

Organization structure, social network and teamwork concept on dark background. Business people icon on wooden cube blocks connecting network of connections.

Myelodysplastic Syndromes

Study identifies nonmutational p53 dysfunction as MDS risk factor

by Leah Sherwood
May 13, 2025
0 Comments

Myelodysplastic Syndromes

FDA grants Orphan Drug designation for bexmarilimab in MDS

by SOHO Insider Editors
May 12, 2025
0 Comments

Myelodysplastic Syndromes

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

by Leah Sherwood
March 17, 2025
0 Comments

Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News Society Updates

Abstract submissions now open for SOHO 2025

by Leah Sherwood
February 14, 2025
0 Comments

Leukemia Myelodysplastic Syndromes News

Is unrelated cord blood better than bone marrow in haploidentical transplantation?

by SOHO Insider Editors
February 4, 2025
0 Comments

Myelodysplastic Syndromes

Dr. Garcia-Manero discusses mature data on luspatercept’s efficacy in MDS

by Leah Sherwood
January 22, 2025
0 Comments

Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes News

FDA grants fast track designation to LYT-200 in AML

by Leah Sherwood
January 17, 2025
0 Comments

Leukemia Myelodysplastic Syndromes

FDA approves imatinib oral solution to treat leukemia, other cancers

by Leah Sherwood
January 4, 2025
0 Comments

Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

by Leah Sherwood
January 3, 2025
0 Comments

Myelodysplastic Syndromes News

CHMP announces positive opinion for imetelstat in lower-risk MDS treatment

by SOHO Insider Editors
December 19, 2024
0 Comments

1
2

Top Categories

Cellular Therapy

12

Leukemia

38

Lymphoma

38

Multiple Myeloma

28

Myelodysplastic Syndromes

13

Myeloproliferative Neoplasms

8

POPULAR NEWS

Leukemia , Lymphoma , Multiple Myeloma , Myelodysplastic Syndromes , Myeloproliferative Neoplasms , News , Society Updates

Abstract submissions now open for SOHO 2025

February 14, 2025

Leukemia , Acute Myeloid Leukemia , Myelodysplastic Syndromes

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

January 3, 2025

66th American Society of Hematology Annual Meeting & Exposition , Leukemia

Asciminib benefit-risk profile bests other TKIs in CML

December 10, 2024

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

MDS News

Study identifies nonmutational p53 dysfunction as MDS risk factor

FDA grants Orphan Drug designation for bexmarilimab in MDS

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

Abstract submissions now open for SOHO 2025

Is unrelated cord blood better than bone marrow in haploidentical transplantation?

Dr. Garcia-Manero discusses mature data on luspatercept’s efficacy in MDS

FDA grants fast track designation to LYT-200 in AML

FDA approves imatinib oral solution to treat leukemia, other cancers

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

CHMP announces positive opinion for imetelstat in lower-risk MDS treatment

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

Enrolling now: quizartinib plus standard therapy for newly-diagnosed AML

Phase 3 MIDAS trial assesses MRD-driven approach to consolidation, maintenance therapy in myeloma

NCCN recommends pemivibart for BCL patients at risk of severe COVID-19

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

MDS News

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms